State of New Jersey Common Pension Fund D’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-78,397
| Closed | -$1.98M | – | 1672 |
|
|
2023
Q2 | $1.98M | Buy |
78,397
+8,176
| +12% | +$255K | 0.01% | 1557 |
|
|
2023
Q1 | $2.26M | Sell |
70,221
-31,987
| -31% | -$997K | 0.01% | 1247 |
|
|
2022
Q4 | $1.89M | Sell |
102,208
-15,699
| -13% | -$359K | 0.01% | 1572 |
|
|
2022
Q3 | $3.18M | Buy |
+117,907
| New | +$2.39M | 0.01% | 795 |
|
|
2022
Q2 | – | Sell |
-200,094
| Closed | -$3.9M | – | 1784 |
|
|
2022
Q1 | $3.9M | Buy |
+200,094
| New | +$3.03M | 0.01% | 831 |
|
|
2021
Q4 | – | Sell |
-101,615
| Closed | -$2.83M | – | 1802 |
|
|
2021
Q3 | $2.83M | Buy |
101,615
+13,852
| +16% | +$395K | 0.01% | 1181 |
|
|
2021
Q2 | $2.6M | Buy |
87,763
+4,672
| +6% | +$135K | 0.01% | 1292 |
|
|
2021
Q1 | $2.32M | Hold |
83,091
| – | – | 0.01% | 1448 |
|
|
2020
Q4 | $2.35M | Buy |
83,091
+2,093
| +3% | +$54.2K | 0.01% | 1386 |
|
|
2020
Q3 | $2.04M | Sell |
80,998
-13,104
| -14% | -$344K | 0.01% | 1363 |
|
|
2020
Q2 | $2.3M | Buy |
+94,102
| New | +$1.86M | 0.01% | 1153 |
|
|
2019
Q3 | – | Sell |
-26,000
| Closed | -$337K | – | 1651 |
|
|
2019
Q2 | $337K | Hold |
26,000
| – | – | ﹤0.01% | 889 |
|
|
2019
Q1 | $410K | Hold |
26,000
| – | – | ﹤0.01% | 876 |
|
|
2018
Q4 | $523K | Hold |
26,000
| – | – | ﹤0.01% | 866 |
|
|
2018
Q3 | $646K | Hold |
26,000
| – | – | ﹤0.01% | 878 |
|
|
2018
Q2 | $714K | Hold |
26,000
| – | – | ﹤0.01% | 897 |
|
|
2018
Q1 | $801K | Hold |
26,000
| – | – | ﹤0.01% | 879 |
|
|
2017
Q4 | $930K | Hold |
26,000
| – | – | ﹤0.01% | 851 |
|
|
2017
Q3 | $716K | Hold |
26,000
| – | – | ﹤0.01% | 877 |
|
|
2017
Q2 | $686K | Hold |
26,000
| – | – | ﹤0.01% | 859 |
|
|
2017
Q1 | $541K | Hold |
26,000
| – | – | ﹤0.01% | 879 |
|
|
2016
Q4 | $538K | Hold |
26,000
| – | – | ﹤0.01% | 868 |
|
|
2016
Q3 | $421K | Hold |
26,000
| – | – | ﹤0.01% | 878 |
|
|
2016
Q2 | $354K | Hold |
26,000
| – | – | ﹤0.01% | 901 |
|
|
2016
Q1 | $454K | Hold |
26,000
| – | – | ﹤0.01% | 893 |
|
|
2015
Q4 | $888K | Hold |
26,000
| – | – | ﹤0.01% | 858 |
|
|
2015
Q3 | $774K | Hold |
26,000
| – | – | ﹤0.01% | 864 |
|
|
2015
Q2 | $831K | Hold |
26,000
| – | – | ﹤0.01% | 857 |
|
|
2015
Q1 | $539K | Hold |
26,000
| – | – | ﹤0.01% | 894 |
|
|
2014
Q4 | $440K | Hold |
26,000
| – | – | ﹤0.01% | 925 |
|
|
2014
Q3 | $503K | Hold |
26,000
| – | – | ﹤0.01% | 891 |
|
|
2014
Q2 | $884K | Buy |
+26,000
| New | +$815K | ﹤0.01% | 847 |
|
Other funds holding RVNC
PAI
PCH
State of New Jersey Common Pension Fund D's RVNC Position: Q3 2023 in Review
State of New Jersey Common Pension Fund D sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2023, closing a stake of 78,397 shares — an estimated $1.98M sold.
State of New Jersey Common Pension Fund D first reported a position in RVNC in Q2 2014 and held it in 32 quarters. The position peaked at $3.9M in Q1 2022. 186 funds tracked by Wall St. Rank hold RVNC as of Q3 2023.
- State of New Jersey Common Pension Fund D reported no remaining Revance Therapeutics, Inc. position as of Q3 2023 after selling out during the quarter.
- State of New Jersey Common Pension Fund D sold 78,397 Revance Therapeutics, Inc. shares in Q3 2023, an estimated $1.98M.
- State of New Jersey Common Pension Fund D first reported a position in Revance Therapeutics, Inc. in Q2 2014 and held it in 32 quarters.
- State of New Jersey Common Pension Fund D's Revance Therapeutics, Inc. position peaked at $3.9M in Q1 2022.
- 186 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2023.
Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2023, filed 8 Nov 2023.